Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

What's new

Study identifies immune–metabolic pathway as potential target in diabetic heart disease

Researchers have shown that a drug originally developed to lower blood sugar can improve heart function and reduce inflammation in a preclinical model of type 2 diabetes.

Cardiovascular Innovation Awards kick-off event inspires researchers to explore translation and commercialisation pathways

The BHF Oxford Centre of Research Excellence (BHF Oxford CRE) launched the Cardiovascular Innovation Awards (CIA) with an energising kick off event at the Saïd Business School, University of Oxford on Friday 6th February.

The Oxford-Harrington Rare Disease Centre Advances Discovery of Therapies for Friedreich’s Ataxia (FA)

Many congratulations to BHF Oxford CRE's PI Chris Toepfer who is one of the five Oxford researchers awarded philanthropic funding from the FA Alliance Innovation Fund to support development of novel therapeutics.

BHF Oxford CRE Annual Symposium 2025

The Oxford cardiovascular community came together at the Town Hall on Wednesday 26th November for the BHF Oxford CRE annual symposium, a chance to share diverse and exciting research from across the network.